Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and midazolam effects on cyclopropofol-induced respiratory depression (ED50 study)
ChiCTR2100051668Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: EEG bispectral index (BIS). Planned start Oct 2021; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2100051668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051668.